Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

MOLECULE DRAMATIQUE : revenue, balance sheet and financial ratios

MOLECULE DRAMATIQUE is a French company founded 7 years ago, specialized in the sector Production de films pour le cinéma. Based in AUBERVILLIERS (93300), this company of category PME shows in 2022 a net income negative of -1 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - MOLECULE DRAMATIQUE (SIREN 847863818)
Indicator 2022
Revenue N/C
Net income -1 033 €
EBITDA N/C
Net margin N/C

Revenue and income statement

In 2022, MOLECULE DRAMATIQUE records a net loss of 1 k€. This deficit will reduce equity on the balance sheet.

Net income (2022) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-1 033 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 355%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 22%. The balance between equity and debt is satisfactory.

Debt ratio (2022) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

354.97%

Financial autonomy (2022) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

21.979%

Asset age ratio (2022) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

70.8%

Solvency indicators evolution
MOLECULE DRAMATIQUE

Sector positioning

Debt ratio
354.97 2022
2022
Q1: 0.0
Med: 5.32
Q3: 75.08
Watch

In 2022, the debt ratio of MOLECULE DRAMATIQUE (354.97) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.

Financial autonomy
21.98% 2022
2022
Q1: 2.37%
Med: 28.48%
Q3: 68.18%
Average

In 2022, the financial autonomy of MOLECULE DRAMATIQUE (22.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Positioning of MOLECULE DRAMATIQUE in its sector

Comparison with sector Production de films pour le cinéma

Similar companies (Production de films pour le cinéma)

Compare MOLECULE DRAMATIQUE with other companies in the same sector:

Frequently asked questions about MOLECULE DRAMATIQUE

What is the revenue of MOLECULE DRAMATIQUE ?

The revenue of MOLECULE DRAMATIQUE is not publicly disclosed (confidential accounts filed with INPI).

Is MOLECULE DRAMATIQUE profitable?

MOLECULE DRAMATIQUE recorded a net loss in 2022.

Where is the headquarters of MOLECULE DRAMATIQUE ?

The headquarters of MOLECULE DRAMATIQUE is located in AUBERVILLIERS (93300), in the department Seine-Saint-Denis.

Where to find the tax return of MOLECULE DRAMATIQUE ?

The tax return of MOLECULE DRAMATIQUE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does MOLECULE DRAMATIQUE operate?

MOLECULE DRAMATIQUE operates in the sector Production de films pour le cinéma (NAF code 59.11C). See the 'Sector positioning' section above to compare the company with its competitors.